Pharmaceutical composition for preventing or treating atopic disease containing Akkermansia muciniphila strain
AssigneeEnterobiome Inc.
InventorsJae-Gu Seo, Joo-Hyun Shin, Dokyung Lee, Yoonmi Lee, Seo Yul Jang, Hye Rim Byeon
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition containing an Akkermansia muciniphila EB-AMDK19 strain or a culture or dried product thereof and uses thereof are disclosed. The composition is effective for the prevention or treatment of atopic disease. The pharmaceutical composition exhibits a preventive or therapeutic effect on atopic disease at the same level as that of steroid-based drugs, and thus is not only promising as pharmabiotics, but also useful in the development of food and cosmetics.
Claims12
A method for alleviating or ameliorating asthma, atopic dermatitis, urticaria, or allergic rhinitis in a subject in need thereof, comprising administering a composition comprising an Akkermansia muciniphila EB-AMDK19 strain (KCTC13761BP) as an active ingredient.
Dependencies are inferred from the claim text.